When prostate cancer has metastasized, and hormone therapy is no longer effective, or when chemotherapy fails or causes ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

ANDROGEN deprivation therapy (ADT) has been the cornerstone of treatment for advanced castration-sensitive prostate cancer ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in ...

Opens in a new tab or window In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen deprivation therapy (ADT) and chemotherapy more ...

Prostate cancer is a form of cancer that develops ... less commonly, cryosurgery; hormonal therapy and chemotherapy are generally reserved for cases of advanced disease (although hormonal therapy ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Prostate cancer is Australia's most commonly diagnosed ... delaying the need for hormone therapy or chemotherapy. Stereotactic radiation therapy is delivered daily, with painless radiation beams.

Some prostate cancers can be cured with treatments such as surgery and radiotherapy. Hormone therapy may also slow cancer growth. It may also be possible to destroy the cancer cells using extreme ...

Sep. 4, 2024 — A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay ...

A more advanced form of radiation may be able to treat early and advanced prostate cancers. Here’s how it works and why it ...